Stanford stem cell biologists have found a way to block a signal that causes growth of breast cancer cells, opening potential for new treatments.
Stanford-led research finds that the blood-brain barrier may be much more permeable -- albeit selectively so -- than previously thought.
Stanford researchers have found a good drug target for treating Diamond-Blackfan anemia, a genetic disease that impairs red blood cell formation.
Stanford scientists have devised a way to use positron emission tomography to watch the movement of a single cell injected into a lab mouse in real time.
How exactly does the antiviral drug remdesivir counter SARS-CoV-2 – the coronavirus strain responsible for COVID-19? And how well?
Even if chloroquine and hydroxychloroquine don't end up being the best treatment for COVID-19, observing how they work in a dish can teach scientists a lot.
Research shows that misshapen proteins called prions can help yeast cells survive environmental threats, such as a lack of food and common antifungal drugs.
The discovery of a giant cavity in a key tuberculosis molecule could open the way for better understanding of the disease.
The bacteria in our gut make tiny, previously unidentified proteins that could shed light on human health and advance drug development.
Understanding the roles of various microbes in the human microbiome is challenging, but statistics can help, Stanford researcher Susan Holmes explains.
Your trillions-strong ecosystem of gut microbes, in addition to its many other responsibilities, operates as a homespun pharmaceutical factory.
A profile by The Scientist of Lucy Shapiro, PhD, highlights her career and the passions that guided her groundbreaking scientific research.
Propionate molecules made by intestinal bacteria inhibits growth of Salmonella and may be a promising new treatment for gut infections.
In an interview, Stanford bioengineer Michael Fischbach discussed the growing knowledge of the bacteria in our bodies and what that means for the future of medicine.
A hitherto unheralded set of telltale enzymes may prove to be perfect targets for shooting down a gang of nasty bacterial pathogens collectively called S. aureus.
Renowned microbe enthusiast Stanley Falkow has died at 84. Falkow was known for his generosity, wit and remarkable scientific acumen that led to the founding of the modern field of bacterial pathogenicity — the study of how bacteria cause human disease.